← All stocks

Avalo Therapeutics, Inc.

AVTX Net buying
CIK 0001534120 #2500 in the set updated 17 Sep 2026
Bought (120 mo)
$60.46M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$10.47M
$565.64K on a plan · $7.69M straight out of an exercise
Sold at will
$2.22M
3 of 45 sales
Net
+$49.99M
+$58.24M against sales at will

By person

26 insiders · 635 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
ARMISTICE CAPITAL, LLC entity
10% owner
$58.19M (515)
$2.17M (2)
+$56.02M
88,947,543
$1.57B
+368.1%
Sullivan Christopher Ryan
Chief Financial Officer
$21.58K (4)
$3.52M (16) scheduled
−$3.50M
39,900
$703.03K
Doyle Mittie
Chief Medical Officer
$2.98M (17) scheduled
−$2.98M
51,776
$912.28K
+399.1%
Caissa Capital Management ltd. entity
10% owner
$1.68M (34)
+$1.68M
0
$0.00
−100.0%
VARKI PAUL
Chief Legal Officer
$1.51M (5) scheduled
−$1.51M
32,576
$573.98K
+214.0%
COLA MICHAEL F
Chief Executive Officer
$250.00K (1)
+$250.00K
175,746
$3.10M
Goldman Jonathan
Director
$162.94K (2) scheduled
−$162.94K
3,166
$55.78K
Harrell James Archie Jr
Chief Commercial Officer
$91.83K (8)
+$91.83K
36,766
$647.81K
Chan Mitchell
Director
$72.46K (1) scheduled
−$72.46K
3,166
$55.78K
Riley Jennifer
Chief Strategy Officer
$52.01K (1)
−$52.01K
37,041
$652.65K
+451.1%
Pedder Simon
Executive Chairman of the Bd
$50.44K (2)
+$50.44K
241,833
$4.26M
NEIL GARRY ARTHUR
Chief Executive Officer
$50.30K (6)
+$50.30K
190,314
$3.35M
Greenleaf Peter
Director
$49.75K (1)
+$49.75K
112,500
$1.98M
Calias Pericles
Chief Scientific Officer
$21.25K (2)
+$21.25K
52,462
$924.36K
+1,516%
Hacksell Uli
Director
$14.90K (2)
+$14.90K
20,000
$352.39K
Almenoff June Sherie
Director
$12.75K (2)
+$12.75K
4,167
$73.42K
Wilkins H Jeffrey
Chief Medical Officer
$12.08K (2)
+$12.08K
33,373
$588.02K
+27.9%
Miller Joseph M
Director
$10.76K (2)
+$10.76K
40,582
$715.04K
Greenway Schond L.
CFO
$5.25K (2)
+$5.25K
3,883
$68.42K
+288.3%
Jones Randal
Director
$5.05K (1) scheduled
−$5.05K
2,592,458
$45.68M
0.0%
Phillips Matthew V
Chief Commercial Officer
$2.90K (2)
+$2.90K
513,520
$9.05M
Moscato Robert Jr.
Director
$504.45 (1)
+$504.45
2,592,743
$45.68M
0.0%
Crutcher Patrick J
VP, Business Development
1,634,771
$28.80M
KAPLAN GILLA
Director
6,333
$111.59K
Truex Samantha
Director
6,333
$111.59K
KANTOFF AARON
Director
6,333
$111.59K

No percentages here. This company's share count has moved by a factor of 5.2 over the window, from 10,393,954 to 53,629,989 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Sullivan Christopher Ryan
10 Sep 2026
Chief Financial Officer
Sold after exercise
10,185
$17.62
$179.46K
Doyle Mittie
28 Aug 2026
Chief Medical Officer
Sold after exercise
679
$20.00
$13.58K
Sullivan Christopher Ryan
18 Aug 2026
Chief Financial Officer
Sold after exercise
31,031
$20.05
$622.32K
Doyle Mittie
17 Aug 2026
Chief Medical Officer
Sold after exercise
1,000
$20.00
$20.00K
Sullivan Christopher Ryan
17 Aug 2026
Chief Financial Officer
Sold after exercise
3,749
$19.94
$74.76K
Sullivan Christopher Ryan
17 Aug 2026
Chief Financial Officer
Sold after exercise
37,945
$19.85
$753.33K
Doyle Mittie
10 Aug 2026
Chief Medical Officer
Sold after exercise
679
$20.00
$13.58K
Doyle Mittie
27 Jul 2026
Chief Medical Officer
Sold after exercise
1,000
$20.00
$20.00K
Doyle Mittie
30 Jun 2026
Chief Medical Officer
Sold after exercise
4,654
$20.00
$93.08K
Doyle Mittie
23 Jun 2026
Chief Medical Officer
Sold after exercise
1,450
$18.00
$26.10K
Doyle Mittie
28 May 2026
Chief Medical Officer
Sold after exercise
679
$16.00
$10.86K
Doyle Mittie
15 May 2026
Chief Medical Officer
Sold after exercise
3,000
$18.76
$56.28K
Sullivan Christopher Ryan
7 May 2026
Chief Financial Officer
Sold after exercise
18,606
$24.12
$448.82K
Doyle Mittie
6 May 2026
Chief Medical Officer
Sold after exercise
10,058
$22.88
$230.13K
Doyle Mittie
6 May 2026
Chief Medical Officer
Sold after exercise
19,015
$22.41
$426.05K
Doyle Mittie
6 May 2026
Chief Medical Officer
Sold after exercise
44,944
$21.20
$952.67K
Doyle Mittie
6 May 2026
Chief Medical Officer
Sold after exercise
5,000
$19.65
$98.25K
Doyle Mittie
6 May 2026
Chief Medical Officer
Sold after exercise
27,538
$18.03
$496.41K
Sullivan Christopher Ryan
6 May 2026
Chief Financial Officer
Sold after exercise
8,900
$22.57
$200.91K
Sullivan Christopher Ryan
6 May 2026
Chief Financial Officer
Sold after exercise
9,219
$21.37
$197.01K
Sullivan Christopher Ryan
6 May 2026
Chief Financial Officer
Sold after exercise
2,700
$20.76
$56.05K
Sullivan Christopher Ryan
6 May 2026
Chief Financial Officer
Sold after exercise
12,347
$19.28
$238.09K
Sullivan Christopher Ryan
6 May 2026
Chief Financial Officer
Sold after exercise
13,834
$18.55
$256.66K
VARKI PAUL
6 May 2026
Chief Legal Officer
Sold after exercise
400
$23.71
$9.48K
VARKI PAUL
6 May 2026
Chief Legal Officer
Sold after exercise
9,253
$22.70
$210.03K
VARKI PAUL
6 May 2026
Chief Legal Officer
Sold after exercise
22,839
$21.22
$484.54K
VARKI PAUL
6 May 2026
Chief Legal Officer
Sold after exercise
5,196
$19.78
$102.78K
VARKI PAUL
6 May 2026
Chief Legal Officer
Sold after exercise
37,375
$18.91
$706.84K
Doyle Mittie
5 May 2026
Chief Medical Officer
Sold after exercise
1,679
$16.00
$26.86K
Doyle Mittie
6 Apr 2026
Chief Medical Officer
Sold after exercise
3,970
$18.01
$71.51K
Doyle Mittie
1 Apr 2026
Chief Medical Officer
Sold after exercise
679
$16.00
$10.86K
Doyle Mittie
16 Mar 2026
Chief Medical Officer
Sold after exercise
25,492
$16.15
$411.61K
Goldman Jonathan
14 Nov 2025
Director
Sold after exercise
8,200
$14.35
$117.65K
Goldman Jonathan
14 Nov 2025
Director
Sold after exercise
3,167
$14.30
$45.29K
Showing 250 of 635 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 436
Amendments (4/A) skipped 3
Filings about a different issuer 1
Unreadable filings 0
Joint filings 81
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 35
Sales at will 3
Transactions with no price 1
Shares from compensation/vesting 57,845,879
History held since 3 Oct 2016